凝血酶原活动度

结论高龄，高胆红素，凝血酶原活动度降低并发肝性脑病、消化道出血、肝肾综合征及严重感染是重型肝炎预后不良的因素。

Conclusion Aged people , high bilirubin , low PTA , and complicated with encephalopathy , gastrointestinal hemorrhage , hepatorenal syndrome and severe infection are bad parameters in patients with SH.

结论凝血酶原活动度、尿素氮、血钠、肝性脑病作为独立的危险因素可用于预后评分系统的构建。

Conclusions The factors , including PTA , blood urea and sodium and hepatic coma , are important in building a scoring system to assess the prognosis of hepatitis failure .

与凝血酶原活动度（PTA）及血清白蛋白（ALB）呈负相关。

It was negatively related with plasma prothrombin activity ( PTA ) or plasma albumin level .

目的探讨病毒性肝炎血浆凝血酶原活动度（PTA）与肝组织病变程度的一致性及其存在的问题。

Objective To explore the relationship between plasma prothrombin activity ( PTA ) and histopathological lesion of the liver in patients with viral hepatitis .

重肝患者的凝血酶原活动度PTA≥30%，其存活率为87.5%；

If the plasma prothrombin activity ( PTA ) was higher than 30 % in SVH patients , their survival rate would be 87.5 % ;

目的研究血清白蛋白（ALB）及血浆凝血酶原活动度（PTA）与肝组织病理损害的关系。

Objective To investigate the relationship between serum album ( ALB )、 plasma prothrombin activity ( PTA ) and the pathology of the liver .

术后血小板（PLT）计数、凝血酶原活动度（PT%）及纤维蛋白原含量（FIB）比较，均P<0.05，差异有显著性意义。

There was significant difference in postoperative PLT amount , PT % and the content of FIB between the two groups ( P < 0 05 ) .

观察患者临床症状、血清内毒素、细胞因子、肝肾功能、电解质、凝血酶原活动度（PTA）、血氨和血常规的变化以及治疗组与对照组疗效的比较。

The results of serum endotoxin , cell factors , liver function , renal function , electrolyte , prothrombin time activity ( PTA ), blood ammonia , blood routine before and after the treatment were analyzed .

目的研究血浆胆碱酯酶（CHE）、清蛋白（ALB）及凝血酶原活动度（PTA）与病毒性肝炎临床分型、病情及预后之间的关系。

Objective To investigate the relationship between the level of cholinesterase ( CHE ) and albumin ( ALB ) in plasma and the prothrombin activity ( PTA ) and the clinical type , disease condition and prognosis in the viral hepatitis patients .

重型肝炎患者血浆凝血酶原活动度动态变化及其意义

Clinical significance of plasma prothrombin activity in patients with severe hepatitis

病毒性肝炎患者血清胆碱酯酶、凝血酶原活动度检测的临床意义

Clinical significance of serum cholinesterase and prothrombin activity in patients with viral hepatitis

血浆胆碱酯酶、凝血酶原活动度及清蛋白在病毒性肝炎中的临床应用

Clinical Application of Plasma Cholinesterase , Prothrombin Activity and Albumin in Patients with Viral Hepatitis

病毒性肝炎血浆凝血酶原活动度与肝组织病变程度的关系

Relationship Between Plasma Prothrombin Activity and Histology of the Liver in Patients with Viral Hepatitis

白蛋白、胆碱酯酶、凝血酶原活动度明显增加（P<0.05）；

The albumin , cholinesterase and prothrombin time were significantly increased ( P < 0.05 ) .

血氧分压明显下降、凝血酶原活动度低下时，应警惕亚急性肝坏死。

When fall of blood oxygen pressure and the degree of prothrombin activity appeared , one should watch out for subacute liver necrosis .

667%患者凝血酶原活动度降低，其中4例低于40%；

The activity of thrombinogen ( PTa ) was decreased in 66.7 % patients , and were less than 40 % in 4 patients ;

前白蛋白、总胆汁酸、凝血酶原活动度及胆固醇检测对肝功能分期及判断预后的临床意义

The clinical significance of the levels of serum prealbumin , total bile acid , prothrombin activity , and cholesterol for the grading of liver function and prognosis

换用组的有效率900%，显效率733%。平均使一例患者的转氨酶、总胆红素、凝血酶原活动度基本恢复正常的费用，与单纯药物治疗的费用比分别为1：1.40、1：1.42和1：1.41。

Results The cost for total bilirubin ( TBIL ), serum transaminase and prothrombin activity recovered in common internal treatment group were 1.40, 1.42 and 1.41 times of plasma exchange group .

结果治疗组在降酶、退黄，提高血清白蛋白、升高凝血酶原活动度，以及治疗有效率等方面均优于对照组，差异具有显著性。

Results It was more prominent of decrease icterus index , increase seralbumin , the activity of prothrombin and the effective rate in the trial group than in the control group .

结果：1.治疗组可明显降低患者血氨、谷丙转氨酶、总胆红素，同时显著提高凝血酶原活动度，治疗效果优于对照组，差距具有统计学意义。

Significantly lower in patients treated ammonia , alanine aminotransferase , total bilirubin , while significantly improving prothrombin activity , the treatment effect than the control group , the difference was statistically significant . 2 .

总胆固醇、胆碱脂酶、白蛋白、凝血酶原活动度越低，预后越差。有肝肾综合征、肝脑综合征有出血者、自发性细菌性腹膜炎者，预后越差。

[ Results ] Single factor analysis showed poor prognosis in having ascites , small liver size , hepatorenal syndrome , hepatic encephalopathy , bleeding and spontaneous bacterial peritonitis and with lowered cholesterol , cholinesterase , albumin , prothrombin activity .

结论：年龄大小不同、病因不同、凝血酶原活动度、胆碱酯酶活力、并发症多少均会影响重肝预后。

Conclusion : Ages , causes of the disease , PTA , BuchE , complications and other factors can influence the prognosis of SVH . the toxic action of PZA on liver is greater than that of other antitubercular drugs .

治疗后D∶T比值、凝血酶原活动度及尿胆红素均明显上升，黄疸下降；

Results : Before treatment the ratio of D / T was 60 % in the treatment group , urine bilirubin was negative , while after treatment the ratio of D / T , activity of thrombinogen and urine bilirubin were all rised and jaundice was fallen .

凝血酶原活动度上升[（38.1%±13.2%），P0.01]，部分患者消化道症状明显改善，人工肝治疗慢性重型肝炎治愈及好转率为38.3%，降低了慢性重型肝炎的病死率。

But it could not reduce Interleukin-1 bata ( IL-1 β), Interleukin-6 ( IL-6 ) . The cure and improved rate in patients with chronic severe hepatitis was 38.3 % by therapy of the artificial liver , that could reduce mortality of patients with chronic severe hepatitis .

HBO治疗结束，各个时间点的凝血酶原时间活动度和APTT两项指标与治疗前比较，差异无统计学意义（P>0.05）。

After HBO therapy the levels of prothrombin time activity and APTT did not change significantly at various time points ( P > 0 . 05 ) .

高龄、血浆凝血酶原时间延长、活动度下降、高血浆总胆红素等是急性重症肝炎患者发展成为肝性脑病的潜在危险因素。

The following factors , including the elderly , prolongation of prothrombin time , decrease of prothrombin activity and high level of total bilirubin are the potential risk factors for the development of hepatic encephalopathy from acute sever hepatitis .

凝血酶原活性进一步增加，治疗结束PTA（凝血酶原活动度%）值重庆医科大学博士研究生论文63.9士21.4，Pl人增加率：43.5士41.5%。

The value were 63.9 + 21.4 % , and the rate of increase was 43.5 + 41.5 % .